Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel · Delayed Price · Currency is ILS · Price in ILA 342.20
-19.50 (-5.39%)
Jan 29, 2026, 5:24 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 846.29 million as of January 29, 2026. Its market cap has increased by 811.08% in one year.
Market Cap
846.29M
Enterprise Value
792.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
342.20
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has increased from 368.04M to 846.29M, an increase of 129.95%. That is a compound annual growth rate of 12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 884.83M | 66.27% |
| Dec 31, 2025 | 532.16M | 467.89% |
| Dec 31, 2024 | 93.71M | -48.18% |
| Dec 29, 2023 | 180.84M | -29.06% |
| Dec 30, 2022 | 254.92M | -28.46% |
| Dec 31, 2021 | 356.33M | -8.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 564.11M |
| Geffen Residence & Renewal | 263.65M |
| Matricelf | 163.97M |
| Clal Biotechnology Industries | 50.19M |
| BioLineRx | 41.77M |
| BioLight Life Sciences | 33.94M |
| Evogene | 29.00M |
| XTL Biopharmaceuticals | 26.49M |